CARNEGIE MELLON UNIVERSITY Long-Term Concentrated

CIK: 0001039067 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 7, 2023

Total Value ($000): $182,644 (100.0% shares, 0.0% debt)

Holdings (6)

IEMG ISHARES CORE MSCI EMERGING MARKETS ETF 79.8%

Value ($000) $145,785 Shares 3,121,730 Est. Cost $58.53 Unrealized —

DUOL DUOLINGO INC 19.9%

Value ($000) $36,290 Shares 510,186 Est. Cost $137.73 Unrealized -43.3%

VERA VERA THERAPEUTICS INC. 0.2%

Value ($000) $311 Shares 16,060 Est. Cost $22.12 Unrealized -18.1%

— NEUBASE THERAPEUTICS INC. 0.1%

Value ($000) $179 Shares 939,412 Est. Cost $2.81 Unrealized —

— PREDICTIVE ONCOLOGY INC. 0.0%

Value ($000) $64 Shares 207,144 Est. Cost $0.95 Unrealized —

IHT INNSUITES HOSPITALITY TRUST 0.0%

Value ($000) $17 Shares 10,000 Est. Cost $3.13 Unrealized -46.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
IEMG	ISHARES CORE MSCI EMERGING MARKETS ETF	3,121,730	$145,785	79.8%	$58.53	—	CORE MSCI EMKT	46434G103
DUOL	DUOLINGO INC	510,186	$36,290	19.9%	$137.73	-43.3%	CL A COM	26603R106
VERA	VERA THERAPEUTICS INC.	16,060	$311	0.2%	$22.12	-18.1%	CL A	92337R101
—	NEUBASE THERAPEUTICS INC.	939,412	$179	0.1%	$2.81	—	COM	64132K102
—	PREDICTIVE ONCOLOGY INC.	207,144	$64	0.0%	$0.95	—	COM NEW	74039M200
IHT	INNSUITES HOSPITALITY TRUST	10,000	$17	0.0%	$3.13	-46.2%	SH BEN INT	457919108